Venclexta 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F3UFF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,366
Award facts
- Contract value 100% obligated
- $10,366.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 23, 2026, the Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) with a ceiling value of $10.4K. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to support federal medical procurement needs. The contract's place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 13, 2026. This delivery order is issued under a larger indefinite delivery contract vehicle established between DLA Troop Support Medical and the prime contractor's parent company, Cencora, Inc. (doing business as AmerisourceBergen), valued at $999.99M and extending through December 2031, which serves as a comprehensive global pharmaceutical supply program supporting military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The parent company holds the primary single-award indefinite delivery contract with DLA and demonstrates extensive capability in delivering a diverse pharmaceutical portfolio across multiple therapeutic domains through firm fixed-price delivery orders. The supply of Venclexta, a specialized oncology medication, exemplifies the company's role in fulfilling critical medical commodities required by military treatment facilities and other federal healthcare institutions as part of DLA's broader pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F3UFF?
SPE2DR26F3UFF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F3UFF worth?
The government has obligated $10,366 on SPE2DR26F3UFF.
Is contract SPE2DR26F3UFF an order under another contract?
Yes. SPE2DR26F3UFF is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UFF competed?
The extent of competition for SPE2DR26F3UFF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award